vTv Therapeutics (VTVT) Income from Non-Controlling Interests: 2015-2025

Historic Income from Non-Controlling Interests for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to -$1.6 million.

  • vTv Therapeutics' Income from Non-Controlling Interests fell 55.82% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 11.49%. This contributed to the annual value of -$4.2 million for FY2024, which is 25.77% up from last year.
  • According to the latest figures from Q3 2025, vTv Therapeutics' Income from Non-Controlling Interests is -$1.6 million, which was down 23.46% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Income from Non-Controlling Interests registered a high of -$233,000 during Q2 2021, and its lowest value of -$2.4 million during Q4 2021.
  • For the 3-year period, vTv Therapeutics' Income from Non-Controlling Interests averaged around -$1.3 million, with its median value being -$1.2 million (2024).
  • Examining YoY changes over the last 5 years, vTv Therapeutics' Income from Non-Controlling Interests showed a top increase of 85.64% in 2021 and a maximum decrease of 605.61% in 2021.
  • vTv Therapeutics' Income from Non-Controlling Interests (Quarterly) stood at -$2.4 million in 2021, then skyrocketed by 44.70% to -$1.3 million in 2022, then increased by 28.40% to -$963,000 in 2023, then climbed by 16.61% to -$803,000 in 2024, then crashed by 55.82% to -$1.6 million in 2025.
  • Its Income from Non-Controlling Interests was -$1.6 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$1.1 million in Q1 2025.